KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,544,000 | -95.8% | 20,589 | -95.8% | 0.04% | -95.4% |
| Q2 2015 | $37,116,000 | -40.4% | 492,846 | -60.3% | 0.94% | -45.3% |
| Q1 2015 | $62,312,000 | +65.6% | 1,242,509 | +14.5% | 1.72% | +95.4% |
| Q4 2014 | $37,639,000 | +17.4% | 1,085,315 | +10.9% | 0.88% | +19.1% |
| Q3 2014 | $32,064,000 | -12.3% | 978,752 | +2.7% | 0.74% | +1.0% |
| Q2 2014 | $36,556,000 | -8.4% | 952,715 | -5.1% | 0.73% | +1.1% |
| Q1 2014 | $39,899,000 | +28.4% | 1,003,492 | +20.6% | 0.72% | +15.7% |
| Q4 2013 | $31,069,000 | -11.2% | 831,840 | +8.3% | 0.62% | -25.9% |
| Q3 2013 | $35,007,000 | +16.0% | 767,892 | -31.2% | 0.84% | +34.4% |
| Q2 2013 | $30,187,000 | +112.4% | 1,115,971 | +86.4% | 0.63% | +33.4% |
| Q1 2013 | $14,209,000 | – | 598,851 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |